Literature DB >> 19373263

Intravitreal bevacizumab as an adjunct in a patient with presumed vascularised choroidal tubercular granuloma.

K Babu, P R Murthy, K R Murthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19373263     DOI： 10.1038/eye.2009.83

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  3 in total

1.  Correlation of vascular endothelial growth factor with the clinical regression of tubercular granuloma.

Authors:  Manisha Agarwal; Chanda Gupta; K Varsha Mohan; Pramod K Upadhyay; Vivek Jha
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

2.  Anti-TB monotherapy for choroidal tuberculoma: an observational study.

Authors:  Ashish Khalsa; Anup Kelgaonkar; Soumyava Basu
Journal:  Eye (Lond)       Date:  2021-04-01       Impact factor: 3.775

3.  Bevacizumab for paradoxical worsening treatment adjunct in HIV patient with choroidal tuberculoma.

Authors:  Sahil Jain; Priya Bajgai; Basavaraj Tigari; Kusum Sharma; Aman Sharma; Vishali Gupta; Ramandeep Singh
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-11-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.